Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

Pioglitazone (Pio)

Source date not recordedAnalyse record ↗
Modality
small molecule
Kind
rate-of-aging
Tested by ITP
yes
ITP year first tested
2022
ITP median % ↑ (♂, best cohort)
5.70
ITP median % ↑ (♀, best cohort)
-4.40
ITP P90 % ↑ (♂, best cohort)
2.20
ITP P90 % ↑ (♀, best cohort)
-1.20
ITP sex effect
female
ITP dose (ppm)
100 ppm
ITP age at start (mo)
7 mo; 20 mo
ITP replicated
no
ITP result status
Published (full stats)

ITP cohort detail (2)

YearCohortDose♂ med♀ med♂ P90♀ P90Citation
2022C2022100 ppm5.5%-9.4%2.2%-6.6%↗ paper
2022C2022100 ppm5.7%-4.4%-2.4%-1.2%↗ paper